在阿尔茨海默氏病模型中,西利比宁在抵消神经元亡和突触功能障碍方面的作用
Baohui Zhang1,2, Di Zhang3, Keyan Chen4
1Department of Neurobiology, China Medical University, Shenyang, 110122, China.
Apoptosis : an international journal on programmed cell death
|January 20, 2025
概括
锡比宁通过减少粉样β斑块,神经炎症和神经元亡,有效地对抗阿尔茨海默病 (AD). 这种天然化合物还支持突触功能,为AD治疗提供了一个有前途的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 的特点是氨基酸β (Aβ) 沉积,神经炎症和突触功能障碍.
- 神经细胞亡是一种关键的病理特征,有助于AD的认知衰退.
研究的目的:
- 为了调查silibinin在缓解AD病理方面的治疗潜力.
- 为了评估silibinin在AD模型中对亡和突触功能障碍的影响.
主要方法:
- 使用了APP/PS1转基因小鼠和SH-SY5Y神经母细胞瘤细胞系.
- 评估了Aβ沉积,神经炎症,神经元亡和突触蛋白表达.
- 采用网络药理学来识别西利比宁的分子标.
主要成果:
- 西利比宁显著降低了Aβ积累和神经炎症.
- 西利比宁强烈抑制了神经元的亡,并增强了突触蛋白的表达.
- 确定了Fyn/GluN2B/CaMKIIα通路作为西利比宁对抗Aβ1-42诱导的亡的神经保护作用的关键机制.
结论:
- 西利比宁显示出作为阿尔茨海默病治疗剂的显著潜力.
- 锡利比宁通过减少亡并保持突触完整性来减轻AD病理.
- 在AD模型中,对Fyn/GluN2B/CaMKIIα通路的调节对于西利比宁在AD模型中的有益作用至关重要.
关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.在Aβ沉积过程中,在Fyn/GluN2B/CaMKIIα信号通路中.神经保护是一种神经保护.这里是Silibinin和Silibinin.突触功能障碍 突触功能障碍 突触功能障碍更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
11.8K
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
42.0K
相关概念视频
siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
Role of Neurotransmitters in Memory
410
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
410
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
